William Tai-Wei Ho - Aug 3, 2021 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
President, CEO and CFO, Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
INAB
Transactions as of
Aug 3, 2021
Transactions value $
$0
Form type
4
Date filed
8/3/2021, 04:55 PM
Previous filing
Jul 29, 2021
Next filing
Feb 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INAB Common Stock Conversion of derivative security +3.07K +4.39% 73K Aug 3, 2021 By child F1
holding INAB Common Stock 2.29M Aug 3, 2021 Direct
holding INAB Common Stock 73K Aug 3, 2021 By child
holding INAB Common Stock 36.5K Aug 3, 2021 See footnote F2
holding INAB Common Stock 36.5K Aug 3, 2021 See footnote F2
holding INAB Common Stock 36.5K Aug 3, 2021 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Series A Preferred Stock Conversion of derivative security $0 -2.79K -100% $0.00* 0 Aug 3, 2021 Common Stock 3.07K By child F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering.
F2 The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy.